You have 9 free searches left this month | for more free features.

Capecitabine

Showing 2076 - 2100 of 2,332

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Liver Cancer Trial in St. Gallen (capecitabine plus gemcitabine)

Completed
  • Extrahepatic Bile Duct Cancer
  • +3 more
  • capecitabine plus gemcitabine
  • St. Gallen, Switzerland
    Kantonsspital - St. Gallen
Jun 2, 2012

Metastatic Malignant Tumor to Brain Trial in France (Bevacizumab)

Completed
  • Metastatic Malignant Neoplasm to Brain
  • Caen, France
  • +5 more
Sep 11, 2013

Metastatic Breast Cancer Trial in Russian Federation, United States (Eniluracil, 5-Fluorouracil, Leucovorin)

Unknown status
  • Metastatic Breast Cancer
  • Gilbert, Arizona
  • +15 more
Jul 16, 2012

Enumeration of Circulating Tumor Cells in Rectal Cancer

Unknown status
  • Rectal Cancer
  • radiation therapy
  • capecitabine (625mg/m2,bid,d1-5 qw)and oxaliplatin (85mg/m2 d1 qw)
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 21, 2012

Colorectal Cancer Trial in Switzerland (Capecitabine, irinotecan HCl, oxaliplatin)

Completed
  • Colorectal Cancer
  • Capecitabine
  • +2 more
  • Chur, Switzerland
  • +3 more
Jun 2, 2012

Breast Cancer Trial in Stanford (Capecitabine, RAD001)

Terminated
  • Breast Cancer
  • Stanford, California
    Stanford University School of Medicine
May 24, 2012

Locally Advanced Non-resectable Breast Cancer, Metastatic Breast Cancer Trial in Memphis (Tesetaxel, Capecitabine)

Unknown status
  • Locally Advanced Non-resectable Breast Cancer
  • Metastatic Breast Cancer
  • Memphis, Tennessee
    The West Clinic
May 31, 2012

Breast Cancer Trial in Bern, Zurich (capecitabine, paclitaxel)

Completed
  • Breast Cancer
  • Bern, Switzerland
  • +1 more
May 14, 2012

Colorectal Cancer Trial in Switzerland (capecitabine and oxaliplatin + cetuximab, capecitabine and oxaliplatin)

Completed
  • Colorectal Cancer
  • capecitabine and oxaliplatin + cetuximab
  • capecitabine and oxaliplatin
  • Aarau, Switzerland
  • +17 more
Jun 4, 2012

Renal Cell Cancer Trial in Vienna (Capecitabine, Interferon, Interleukin)

Terminated
  • Renal Cell Cancer
  • Capecitabine, Interferon, Interleukin
  • Vienna, Austria
    Univ. Klinik f. Innere Medizin, Abt. Onkologie
May 15, 2012

Breast Cancer Trial in St. Gallen (capecitabine, vinorelbine tartrate)

Completed
  • Breast Cancer
  • capecitabine
  • vinorelbine tartrate
  • St. Gallen, Switzerland
    Kantonsspital - St. Gallen
May 14, 2012

Solid Tumor Trial in Birmingham, Detroit, San Antonio (DJ-927, capecitabine)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Birmingham, Alabama
  • +2 more
May 15, 2012

Hepatocellular Carcinoma Trial in New Delhi (Oral, Supportive)

Unknown status
  • Hepatocellular Carcinoma
  • New Delhi, Delhi, India
    All India Institute of Medical Sciences
Jul 12, 2012

Metastatic Colorectal Cancer Trial in Vienna (Bevacizumab)

Completed
  • Metastatic Colorectal Cancer
  • Vienna, Austria
    Medical University Hospital Vienna
Jan 29, 2013

Hilar Cholangiocarcinoma, Primary Sclerosing Cholangitis Trial in Padova (procedure, radiation, drug)

Unknown status
  • Hilar Cholangiocarcinoma
  • Primary Sclerosing Cholangitis
  • Liver transplantation
  • +4 more
  • Padova, Italy
    Azienda Ospedaliera di Padova
Jul 17, 2012

Pancreatic Cancer Trial in Goyang (Capecitabine (Xeloda®), Localization, simulation and immobilization)

Unknown status
  • Pancreatic Cancer
  • Capecitabine (Xeloda®)
  • Localization, simulation and immobilization
  • Goyang, Gyeonggi, Korea, Republic of
    National Cancer Center Korea
Apr 2, 2012

Rectal Cancer Trial in Ljubljana (cetuximab, capecitabine)

Unknown status
  • Rectal Cancer
  • cetuximab, capecitabine
  • Ljubljana, Slovenia
    Institute of Oncology
Mar 23, 2012

Esophageal Tumors, Carcinoma, Squamous Cell, Adenocarcinoma Trial in Stanford (Capecitabine (Xeloda), [18-F] Fluorodeoxyglucose

Terminated
  • Esophageal Neoplasms
  • +3 more
  • Capecitabine (Xeloda)
  • +3 more
  • Stanford, California
    Stanford University School of Medicine
Jul 13, 2012

Gastric Cancer Trial in Lublin (Postoperative Chemotherapy)

Unknown status
  • Gastric Cancer
  • Postoperative Chemotherapy
  • Lublin, Lubelskie, Poland
  • +1 more
Feb 6, 2013

Rectal Cancer Trial (Proton Therapy, Capecitabine)

Withdrawn
  • Rectal Cancer
  • Proton Therapy
  • Capecitabine
  • (no location specified)
Mar 21, 2012

Malignancies Trial in Chicago (satraplatin and capecitabine)

Terminated
  • Malignancies
  • satraplatin and capecitabine
  • Chicago, Illinois
    Northwestern University Medical Center
Mar 21, 2012

Pancreatic Cancer, Biliary Cancer Trial in San Francisco, Salt Lake City (gemcitabine, capecitabine)

Completed
  • Pancreatic Cancer
  • Biliary Cancer
  • San Francisco, California
  • +1 more
Apr 3, 2012

Locally Advanced Rectal Cancer Trial in Ljubljana (bevacizumab, capecitabine)

Unknown status
  • Locally Advanced Rectal Cancer
  • bevacizumab, capecitabine
  • Ljubljana, Slovenia
    Onstitute of Oncology, Zaloška 2
Mar 23, 2012

Liver Metastases, Colorectal Cancer Trial in Harbin, Shenyang (bevacizumab plus chemo)

Unknown status
  • Liver Metastases
  • Colorectal Cancer
  • bevacizumab plus chemotherapy
  • Harbin, Heilongjiang, China
  • +1 more
Jan 28, 2013

Gastric Carcinoma Trial in Seoul (Tesetaxel-capecitabine-cisplatin)

Unknown status
  • Gastric Carcinoma
  • Seoul, Korea, Republic of
    Yonsei Cancer Center, Yonsei University College of Medicine
Mar 11, 2012